ClinicalTrials.govpublic full text
HVA vs IA/DA or VA in the Treatment of ND HR-AML
newly diagnosed acute myeloid leukemia with high risk, hva regimen, intensive chenmotherapy, fit, randomized controlled trial, phase 3, ven combined with aza, unfit, newly diagnosed, high risk, acute myeloid leukemia, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840678
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.